Disease Areas
News on disease research and therapeutic development trends in precision medicine.
Neurogene Doses First Two Rett Syndrome Patients in Gene Therapy Trial
Participants in the first-in-human trial will receive the firm's NGN-401 gene therapy, which is designed to deliver a working copy of the MECP2 gene.
The company showed early data establishing a rheumatoid arthritis-specific expression signature and is enrolling patients into a larger study.
In Brief This Week: Sernova, Akeso, RoslinCT, GeNeuro, Effector Therapeutics, ARUP Laboratories
News items for the week of Nov. 27, 2023.
University at Buffalo-Led Team Explores Genetic Test to Predict Weight Loss After Bariatric Surgery
Premium
While the research is early stage, investigators so far have identified genetic variants predictive of sustained weight loss one year after surgery.
Role of SPOP Mutations in Prostate, Endometrial Cancer Come Into Focus in Retrospective Analysis
Premium
Using Caris Life Sciences' database, researchers found that prostate and endometrial cancers with SPOP mutations have distinct immune characteristics.
Nov 30, 2023
Nov 29, 2023